Lead transport and binding by human erythrocytes in vitro

Area of Science:

• Human Physiology
• Toxicology
• Biochemistry

Background:

• Lead (Pb2+) is a toxic heavy metal with known adverse health effects.
• Understanding lead transport and binding in cells is crucial for assessing lead toxicity.
• Erythrocytes (red blood cells) are a primary target for lead accumulation in the body.

Purpose of the Study:

• To investigate the mechanisms of lead (Pb2+) transport across the human erythrocyte membrane.
• To quantify lead binding within erythrocytes.
• To elucidate the reasons for the high erythrocyte-to-plasma lead ratio observed in vivo.

Main Methods:

• Utilized the radioactive isotope 203Pb to trace lead transport and binding.
• Examined cells with lead (Pb2+) contents in the 1-10 microM range.
• Investigated Pb2+ transport via the anion exchanger and a vanadate-sensitive pathway (Ca2+ pump).

Main Results:

• Pb2+ enters erythrocytes through the anion exchange system.
• Pb2+ exits erythrocytes via a vanadate-sensitive pathway, likely the Ca2+ pump, but at a lower rate than previously reported.
• Pb2+ distribution across the erythrocyte membrane is near equilibrium, suggesting intracellular binding.
• A labile Pb2+-binding component in the erythrocyte cytoplasm accounts for the high erythrocyte-to-plasma Pb ratio in vivo.

Conclusions:

• Human erythrocytes transport Pb2+ via specific membrane mechanisms.
• Intracellular binding significantly influences lead distribution and accumulation in erythrocytes.
• The findings provide insight into lead toxicokinetics and the high erythrocyte lead burden observed in vivo.